Genetic Requirements for the survival of Tubercle Bacilli in Nonhuman Primates
非人灵长类结核杆菌生存的遗传要求
基本信息
- 批准号:8473655
- 负责人:
- 金额:$ 73.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcuteAddressAerosolsAgeAlveolarAnabolismAnimalsAntitubercular AgentsAttenuatedAutopsyBacillus (bacterium)BeliefBiological AssayBody TemperatureC-reactive proteinCCL19 geneCCL2 geneCCL7 geneCD4 Positive T LymphocytesCatabolismCaviaCell WallCellsCessation of lifeCharacteristicsCholesterolChromosomesChronicClinicalCommunicable DiseasesConfocal MicroscopyDNA RepairDefectDevelopmentDiseaseDoseDrug resistanceEmergency SituationEnvironmentEnzyme-Linked Immunosorbent AssayExhibitsFailureFamilyFatty AcidsGenesGeneticGenomeGranulomaGranulomatousGrowthHistopathologyHumanHypersensitivity skin testingHypoxiaImmune systemIn Situ HybridizationIndividualInfectionInflammatoryInterleukin-12IrrigationLesionLibrariesLiverLungLung Lavage FluidMacaca mulattaMammalian CellMeasurementMeasuresMetabolismMinorityModelingMonkeysMusMycobacterium tuberculosisNitrate ReductasesNutrientOperonOutputPathogenesisPathologyPathway interactionsPeptidoglycanPharmaceutical PreparationsPhasePhenotypePhosphotransferasesPhysiologicalPlayPrimatesProcessProductionPulmonary TuberculosisRegulonRelative (related person)ReportingResistanceRestReverse Transcriptase Polymerase Chain ReactionRoleSamplingSerumSimian Acquired Immunodeficiency SyndromeSouthern BlottingSpleenStagingSterolsStressSystemTestingTimeTuberculosisTuberculosis VaccinesVaccinesValidationVirulenceVirulence FactorsVirulentWeightarabanattenuationbasehygromycin Aimmune activationimmunopathologyin vivolipid transportlymph nodesmacrophagemalemembermortalitymouse modelmutantnitrate reductasenonhuman primateperipheral bloodpublic health relevanceresearch studyresponsesensortransposon site hybridizationtuberculosis drugsvector
项目摘要
DESCRIPTION (provided by applicant): Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is a global infectious disease emergency. Each year an estimated 8 million people develop, and about two million people die of TB. Synergy with AIDS, the emergence of drug-resistance and the lack of effective anti-TB drugs and vaccines has worsened this situation. New drugs and vaccines are urgently needed to effectively control TB. This requires a better understanding of how Mtb adapts to a wide-variety of environmental conditions, inevitably faced by it during the various stages of infection. Nonhuman Primates (NHPs), arguably, best model critical aspects of TB. Analysis of the mechanisms employed by Mtb to successfully infect and persist in NHP lungs would therefore be very useful. We studied genes essential for growth/survival of Mtb in the NHP lungs experimentally exposed to high doses of aerosols of an Mtb transposon mutant library. In this acute model of TB, 33.13% of all tested mutants were attenuated for in-vivo growth compared to the mouse model where only ~6% of all mutants are attenuated. The Mtb mutants attenuated for in-vivo survival in primates were involved in the transport of lipid virulence factors; biosynthesis of cell-wall arabinan and peptidoglycan, fatty-acids and polyketides; DNA repair; sterol metabolism and mammalian cell-entry (mce). Our study highlights the various virulence-mechanisms employed by Mtb for infection and to overcome the hostile environment encountered during infection of NHP lungs. We would like to leverage our ability to model the various clinical phases of human TB - acute, pulmonary TB, chronic-progressive TB and latent, asymptomatic TB in NHPs - to study the growth/survival phenotype profiles of Mtb mutants. Further, we would like to better understand the role of two Mtb pathways crucial for virulence and pathogenesis, using the NHP model. These include the mce1/mce4 operons, whose members were among mutants that were attenuated for growth in NHP lungs; and members of the dos regulon, which were surprisingly not attenuated in NHP lungs, in-spite of their well-defined roles in latency, persistence and defense against hypoxia.
描述(由申请人提供):结核分枝杆菌(MTB)引起的结核病(TB)是全球感染病紧急情况。每年估计有800万人出现,约有200万人死于结核病。与艾滋病的协同作用,抗药性的出现以及缺乏有效的抗TB药物和疫苗的情况使这种情况恶化了。迫切需要新药和疫苗有效控制结核病。这需要更好地了解MTB如何适应各种环境条件,在感染的各个阶段,它不可避免地面临。可以说,非人类灵长类动物(NHP)是结核病的最佳模型关键方面。因此,对MTB成功感染和持续在NHP肺中使用的机制的分析将非常有用。我们研究了MTB肺中MTB生长/存活至关重要的基因,该基因在实验中暴露于MTB转座子突变库中的高剂量气溶胶。在这种结核病的急性模型中,与小鼠模型相比,所有测试突变体中有33.13%的体内生长被衰减,而小鼠模型只有约6%的突变体被衰减。在灵长类动物的体内存活中,MTB突变体参与了脂质毒力因子的运输。细胞壁阿拉伯糖和肽聚糖,脂肪酸和聚酮化合物的生物合成; DNA修复;固醇代谢和哺乳动物细胞进入(MCE)。我们的研究强调了MTB用于感染的各种毒力机制,并克服了NHP肺部感染期间遇到的敌对环境。我们想利用对人类结核的各种临床阶段进行建模的能力 - 急性,肺结核,慢性促进性结核病和潜在的NHP中无症状TB - 研究MTB突变体的生长/存活表型。此外,我们希望更好地理解使用NHP模型对毒力和发病机理至关重要的两种MTB途径的作用。其中包括MCE1/MCE4操纵子,其成员属于NHP肺增长的突变体之一; DOS Regulon的成员,令人惊讶的是,NHP肺部没有衰减,他们在延迟,持久性和防御性缺氧方面发挥了明确的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deepak Kaushal其他文献
Deepak Kaushal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deepak Kaushal', 18)}}的其他基金
Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis
诱导支气管相关淋巴组织在潜伏性结核病中的作用
- 批准号:
10764569 - 财政年份:2023
- 资助金额:
$ 73.04万 - 项目类别:
Baboon model of long term effects of SARS-CoV-2 infection
SARS-CoV-2 感染长期影响的狒狒模型
- 批准号:
10413419 - 财政年份:2021
- 资助金额:
$ 73.04万 - 项目类别:
Impact of tuberculosis on the development and function of the immune system in SIV-infected infants
结核病对 SIV 感染婴儿免疫系统发育和功能的影响
- 批准号:
10444441 - 财政年份:2021
- 资助金额:
$ 73.04万 - 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
- 批准号:
10757101 - 财政年份:2020
- 资助金额:
$ 73.04万 - 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
- 批准号:
10440359 - 财政年份:2020
- 资助金额:
$ 73.04万 - 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
- 批准号:
10211126 - 财政年份:2020
- 资助金额:
$ 73.04万 - 项目类别:
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
了解骨髓源性抑制细胞在结核病中的功能作用
- 批准号:
10083390 - 财政年份:2020
- 资助金额:
$ 73.04万 - 项目类别:
相似国自然基金
用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
- 批准号:32301097
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
- 批准号:82300739
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
- 批准号:32371426
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
- 批准号:82302221
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
- 批准号:
10706874 - 财政年份:2023
- 资助金额:
$ 73.04万 - 项目类别:
An mHealth implementation strategy to address the syndemic of mental illness, hypertension, and HIV in Uganda
解决乌干达精神疾病、高血压和艾滋病毒综合症的移动医疗实施战略
- 批准号:
10752992 - 财政年份:2023
- 资助金额:
$ 73.04万 - 项目类别:
Host cell membrane perforation during invasion by Toxoplasma gondii
弓形虫入侵过程中宿主细胞膜穿孔
- 批准号:
10587658 - 财政年份:2023
- 资助金额:
$ 73.04万 - 项目类别:
m6A mRNA reader proteins in the AIDS-opportunistic pathogen Toxoplasma gondii
艾滋病机会致病菌弓形虫中的 m6A mRNA 阅读器蛋白
- 批准号:
10615374 - 财政年份:2023
- 资助金额:
$ 73.04万 - 项目类别: